From: Post COVID-19 syndrome in a prospective cohort study of Egyptian patients
Ā | Post COVID-19 symptoms | OR (95 CI%) | Test of significance | |||
---|---|---|---|---|---|---|
No | Yes | |||||
Mean Ā± SD, N (row %) | Mean Ā± SD, N (row %) | Value | p value | Sig. | ||
Age | 51.54 Ā± 16.35 | 61.97 Ā± 13.35 | Ā | t = ā4.527 | < 0.001 | S |
Sex | ||||||
āMale | 39 (60.94%) | 25 (39.06%) | 0.908 (0.48ā1.7) | X2 = 0.088 | 0.767 | NS |
āFemale | 67 (63.21%) | 39 (36.79%) | ||||
Co-morbidities | ||||||
āNo | 43 (75.44%) | 14 (24.56%) | 2.44 (1.2ā4.9) | X2 = 6.255 | 0.012 | S |
āYes | 63 (55.75%) | 50 (44.25%) |